L106

Loxapine succinate salt

solid

• Fórmula empírica (notación de Hill): C₁₈H₁₈ClN₃O · C₄H₆O₄
• Número de CAS: 27833-64-3
• Peso molecular: 445.90
• EC Number: 248-682-0
• MDL number: MFCD00069298
• UNSPSC Code: 12352200
• PubChem Substance ID: 24277719
• NACRES: NA.77

Propiedades

• form: solid
• Quality Level: 100
• color: white
• solubility: H₂O: soluble
• originator: Watson
• SMILES string: CN(CC1)CCN1C2=NC3=C(C=CC=C3)OC4=C2C=C(Cl)C=C4.OC(CCC(O)=O)=O
• InChI: 1S/C18H18ClN3O.C4H6O4/c1-21-8-10-22(11-9-21)18-14-12-13(19)6-7-16(14)23-17-5-3-2-4-15(17)20-18;5-3(6)1-2-4(7)8/h2-7,12H,8-11H2,1H3;1-2H2,(H,5,6)(H,7,8)
• InChI key: YQZBAXDVDZTKEQ-UHFFFAOYSA-N
• Gene Information: human ... DRD2(1813) , DRD3(1814) , DRD4(1815) , HTR2A(3356) , HTR2B(3357) , HTR2C(3358) , HTR7(3363)

Descripción

Biochem/physiol Actions

D₂/D₄ dopamine receptor antagonist; 5-HT_2A/2B, 5-H₇ serotonin receptor antagonist; dibenzoxazepine antipsychotic agent.

Features and Benefits

This compound was developed by Watson. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Información de seguridad

• Storage Class: 11 - Combustible Solids
• wgk_germany: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable
• ppe: Eyeshields, Gloves, type N95 (US)